Jefferies Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Jefferies Group’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,023	Closed	-$489K	–	1893
2021 Q2	$489K	Buy	5,023 +23	+0.5%	+$2.72K	﹤0.01%	1173
2021 Q1	$585K	Hold	5,000	–	–	0.01%	1081
2020 Q4	$556K	Hold	5,000	–	–	﹤0.01%	1094
2020 Q3	$594K	Hold	5,000	–	–	0.01%	937
2020 Q2	$566K	Buy	5,000 +3,500	+233%	+$344K	0.01%	882
2020 Q1	$100K	Sell	1,500 -9,828	-87%	-$819K	﹤0.01%	1791
2019 Q4	$1.03M	Sell	11,328 -15,344	-58%	-$1.49M	0.01%	1443
2019 Q3	$2.3M	Sell	26,672 -19,949	-43%	-$1.87M	0.02%	993
2019 Q2	$4.89M	Buy	46,621 +15,685	+51%	+$1.68M	0.04%	483
2019 Q1	$3.88M	Buy	30,936 +2,057	+7%	+$256K	0.03%	550
2018 Q4	$3.26M	Buy	28,879 +24,269	+526%	+$3.76M	0.03%	600
2018 Q3	$987K	Buy	+4,610	New	+$1.16M	0.01%	1332
2016 Q3	–	Sell	-2,857	Closed	-$26K	–	2368
2016 Q2	$26K	Hold	2,857	–	–	﹤0.01%	2019
2016 Q1	$24K	Hold	2,857	–	–	﹤0.01%	2089
2015 Q4	$35K	Hold	2,857	–	–	﹤0.01%	2152
2015 Q3	$174K	Buy	+2,857	New	+$206K	﹤0.01%	1958
2015 Q2	–	Sell	-92,571	Closed	-$6.29M	–	3424
2015 Q1	$6.29M	Buy	+92,571	New	+$7.94M	0.04%	356
2014 Q4	–	Sell	-25,714	Closed	-$2.71M	–	2193
2014 Q3	$2.71M	Buy	+25,714	New	+$3.58M	0.02%	625
2013 Q4	–	Sell	-777	Closed	-$172K	–	2101
2013 Q3	$172K	Buy	+777	New	+$165K	﹤0.01%	1643

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Jefferies Group's MDGL Position: Q3 2021 in Review

Jefferies Group sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2021, closing a stake of 5,023 shares — an estimated $489K sold.

Jefferies Group first reported a position in MDGL in Q3 2013 and held it in 19 quarters. The position peaked at $6.29M in Q1 2015. 133 funds tracked by Wall St. Rank hold MDGL as of Q3 2021.

Jefferies Group reported no remaining Madrigal Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Jefferies Group sold 5,023 Madrigal Pharmaceuticals shares in Q3 2021, an estimated $489K.
Jefferies Group first reported a position in Madrigal Pharmaceuticals in Q3 2013 and held it in 19 quarters.
Jefferies Group's Madrigal Pharmaceuticals position peaked at $6.29M in Q1 2015.
133 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2021.

Based on Jefferies Group's 13F filing for Q3 2021, filed 15 Nov 2021.